"At 30 June 2011, Alchemia Limited had tax losses of approximately A$72m which it believes it will be able to apply to future profits from fondaparinux. At the same date, Alchemia Oncology has accumulated losses of $52m which it expects to retain following the spin out."
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
1.0¢ |
Change
0.000(0.00%) |
Mkt cap ! $1.409M | |||
| Open | High | Low | Value | Volume |
| 0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
| TSN (ASX) Chart |
Day chart unavailable